Significados do uso de maconha por pessoas com diagnóstico de esquizofrenia
DOI:
https://doi.org/10.34019/1982-1247.2024.v18.36116Palavras-chave:
maconha, esquizofrenia, pesquisa qualitativaResumo
Este estudo teve como objetivo analisar os significados atribuídos ao consumo de maconha por indivíduos com diagnóstico de esquizofrenia. Trata-se de um estudo qualitativo com pessoas que fazem tratamento em um serviço especializado em álcool e drogas. Dentre os significados, foram identificados: 1) Para algumas pessoas, o uso de maconha significa a possibilidade de experimentar prazer e bem-estar; 2) Foi identificado ainda discursos sobre a influência do uso no surgimento e/ou agravamento dos sintomas. 3) Outros diziam sobre consequências sociais e rompimento de vínculos familiares e de trabalho. 4) Para algumas pessoas, o uso estaria associado a discriminação e ilegalidade
Downloads
Referências
Asher, C. J., & Gask, L. (2010). Reasons for illicit drug use in people with schizophrenia: qualitative study. BioMed Central Psychiatry, 10(94), 1-15. doi: 10.1186/1471-244X-10-94.
Becker, H. S. (2008). Outsiders: estudos de sociologia do desvio. Rio de Janeiro, Zahar.
Bechtold, J., Hipwell, A., Lewis, D. A., Loeber, R., & Pardini, D. (2016). Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms. American Journal of Psychiatry, 173(8), 781–789. doi:10.1176/appi.ajp.2016.15070878
Braun, V., & Clarke, V. (2021). Conceptual and design thinking for thematic analysis. Qualitative Psychology. Advance online publication. doi: https://doi.org/10.1037/qup0000196
Clarke, V., & Braun, V. (2013) Successful qualitative research: A practical guide for beginners. London: Sage.
Buadze, A., Stohler, R., Schulze, B., Schaub, M., & Liebrenz, M. (2010). Do patients think cannabis causes schizophrenia? A qualitative study on the causal beliefs of cannabis using patinets with schizophrenia. Harm Reduction Journal, 7(22), 1-8. doi: 10.1186/1477-7517-7-22.
Childs, H. E., Mccarthy-Jones, S., Rowse, G., & Turpim, G. (2011). The journey through cannabis use a qualitative study of the experiences of young adults with psychosis. The Journal of Nervous and Mental Disease, 199(9), 703-708. doi: 10.1097/NMD.0b013e318229d6bd.
Copello, A., Clutterbuck, R., Tobin, D., Orford, J., Preece, M., Birchwood, M., & McGovern, D. (2009). Exploring the attitudes of staff working within mental health settings toward clients who use cannabis. Birmingham & Solihull Mental Health Trust, 16(4), 311-329. doi: 10.1080/09687630801945861.
Corradi-Webster, C. M., Melo, M. C., Leão, E. A., & Vieira, F. S. (2017). Saúde mental e uso de drogas: possibilidades para o cuidado. In: R. M. S. Seabra, (Org.). Boas práticas: caminhos e descaminhos no processo de desinstitucionalização. (1st ed., pp. 181-207) São Paulo: Cultura Acadêmica – UNESP.
Costain, W. F. (2008). The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. International Journal of Mental Health Nursing, 17, 227–235. doi: 10.1111/j.1447-0349.2008.00538.x.
Degenhardt, L., Saha, S., Lim, C. C. W., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., & World Mental Health Survey Collaborators. (2017). The associations between psychotic experiences, and substance use and substance use disorders: Findings from the World Health Organization - World Mental Health Surveys. Addiction. doi: 10.1111/add.14145.
D’Souza, D. C., Sewell, R. A., Ranganathan, M. (2009). Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry Clinical Neuroscience, 259(7), 413–31.
Gill, K. E., Poe, L., Azimov, N., Ben‐David, S., Vadhan, N. P., Girgis, R., & Corcoran, C. M. (2015). Reasons for cannabis use among youths at ultra-high risk for psychosis. Early Intervention in Psychiatry, 9(3), 207-210.
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016). Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the national epidemiologic survey on alcohol and related conditions–III. Am J Psychiatry, 173, 588–599
Katz, G., Durst, R., Shufman, E., Bar-Hamburger, R., & Grunhaus, L. (2010). Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Comprehensive Psychiatry, 51, 37–41. doi: 10.1016/j.comppsych.2009.03.008.
Kolliakou, A., Joseph, C., Ismail, K., Atakan, Z., & Murray, R. M. (2011). Why do patients with psychosis use cannabis and are they ready to change their use? International Journal of Developmental Neuroscience, 29(3), 335-46. doi: 10.1016/j.ijdevneu.2010.11.006.
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Rate of Cannabis Use Disorders in Clinical Samples of Patients with Schizophrenia: A Meta-analysis. Schizophrenia Bulletin, 36(6), 1115– 130. doi:10.1093/schbul/sbp031
Lafaye, G., Karila, L., Blecha, L., & Benyamina, A. (2017). Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience, 19(3), 309-316.
Lobbana, F., Barrowclough, C., Jeffery, S., Bucci, S., Taylor, K., Mallinson, S., & Marshall, M. (2010). Understanding factors influencing substance use in people with recent onset psychosis: A qualitative study. Social Science & Medicine, 70, 1141–1147. doi: 10.1016/j.socscimed.2009.12.026.
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia Bulletin, 42(5), 1262–1269. doi:10.1093/schbul/sbw003
Matheson, S. L., Shepherd, A. M., Laurens, K. R., & Carr, V. J. (2011). A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res, 133(1-3):133–42
Nutt, D. (2012). Drugs without the hot air – minimizing the harms of legal and illegal drugs. UIT, Cambridge, England.
Parshotam, R. K., & Joubert, P. M. (2015). Views of schizophrenia patients on the effects of cannabis on their mental health. South African Journal of Psychiatry, 21, 57.
Pettersen, H., et al. (2013). Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness. Int J of Qual Stud on Health and Well-Being, 8(10), 21968.
Rabin, R. A., & George, T. P. (2017). Understanding the Link Between Cannabinoids and Psychosis. Clinical Pharmacology & Therapeutics, 101(2), 197-199. doi: 10.1002/cpt.421
Seddon, J. L., Copello, A., & Birchwood, M. (2013) Cannabis use and abstention in first-episode psychosis: the participants' view. Mental Health and Substance Use, 6(1), 47-58, doi: 10.1080/17523281.2012.660190
Schneider, J. (2011). Experiências de ruptura de usuários de drogas. Soc. E Cult., 14 (2), 311-320. doi: 10.5216/sec.v14i2.17607
Siqueira, D. F., et al. (2016). Familiar do usuário de substâncias psicoativas: revisão de literatura. Multiciência online. ISSN 2448-4148. Retrieved from: http://www.urisantiago.br/multicienciaonline/adm/upload/v3/n5/02fe22060bbb9f546f81229f7228e6f9.pdf
Souza, J., Kantorski, L., & Mielke, F. (2006). Vínculos e redes sociais de indivíduos dependentes de substâncias psicoativas sob tratamento em CAPS AD. SMAD Revista Eletrônica Saúde Mental Álcool E Drogas (Edição Em Português), 2(1), 01-17.
Sutovic, A. (2017). Psychiatry between Glorification and Stigmatization. Psychiatria Danubina, 29(5), 880-884.
Tong, A., Craig, J., & Sainsbury, P. (2007). Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349 –357. doi: https://doi.org/10.1093/intqhc/mzm042
Wagstaff, C., Graham, H., Farrell, D., Larkin, M., & Tatham, L. (2017). Perspectives of cannabis use in the life experience of men with schizophrenia. International Journal of Mental Health Nursing, 8(1), 1–11. doi: 10.1111/inm.12422.
World Health Organization. (2016). The Health and Social Effects of Nonmedical Cannabis Use. Geneva: World Health Organization. Retrieved from: https://www.who.int/substance_abuse/publications/msbcannabis.pdf
World Health Organization. (2019). World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.8). Retrieved from: https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_5_CANNABIS_HALLUCINOGENS.pdf
